Document Detail


Effects of cocaine administration during early organogenesis on prenatal development and postnatal growth in mice.
MedLine Citation:
PMID:  8835227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cocaine use has been associated with adverse developmental effects in humans. However, clinical reports both confirm and deny an association between cocaine use and malformations. Similarly, differences in species and strain, as well as route and timing of cocaine administration, have added to the difficulties in determining the teratogenicity of cocaine in animal models. This study was undertaken to compare the effects of dose, route, and timing of cocaine administration in ICR mice during early organogenesis. A single intraperitoneal (ip) administration of cocaine ( > or = 60 mg/kg) on Day 9 of gestation (plug day = 1) produced maternal lethality. The predominant developmental effect of cocaine administration was an increase in the percentage of litters exhibiting an enlarged renal pelvis. Despite a high incidence of affected pups at these doses, the enlargement was not severe. These results, in agreement with previous reports, provide further evidence that the developing urogenital system is sensitive to cocaine administration. When cocaine was administered using a subcutaneous route, pup weights were greater and the incidence of enlarged renal pelvis was lower than when an ip route was used. To better mimic human binge cocaine abuse, the toxicity of a "split dose" was determined. A 60 mg/kg dose was administered using one administration of 60 mg/kg, two treatments of 30 mg/kg, or three administrations of 20 mg/kg with 1 hr separating the treatments. The incidence of enlarged renal pelvis was similar when cocaine was administered as one or two but was decreased when cocaine was administered as three treatments. Both the route and split-dose studies suggest that high-peak serum concentrations are required to perturb development. There were no differences in the incidence or severity of enlarged renal pelvis when cocaine was administered on Day 8, 9, or 10 or on all 3 days of gestation. This suggested that the increase in enlarged renal pelvis may not be a specific teratogenic effect of cocaine administration but may be a delay of normal development induced by cocaine exposure during this early period of organogenesis. To address this hypothesis, cocaine was administered on Day 9 using an ip route and the pups were allowed to be naturally born. In pups whose mothers received cocaine there was an increase in postnatal deaths and a trend toward a reduction in pup body weight/litter at Postnatal Day 21. However, when renal morphology was assessed on Postnatal Day 21 no abnormal kidneys were seen. This supports the hypothesis that enlarged renal pelvis produced by cocaine administration during early organogenesis represents a developmental delay and not a persistent teratogenic defect. These studies suggest that high peak cocaine concentrations are required to delay normal kidney morphogenesis in mice.
Authors:
E S Hunter; L E Kotch; R C Cefalo; T W Sadler
Related Documents :
15049517 - Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic ...
2324717 - Small plot test of sustained-release altosid (methoprene) pellets against aedes taenior...
3767527 - Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice.
841307 - Acute systemic effects of cocaine in man: a controlled study by intranasal and intraven...
15864067 - Isolation decreases physical and motivational aspects of morphine withdrawal.
19161457 - Pharmacokinetics of butorphanol in horses after intramuscular injection.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Fundamental and applied toxicology : official journal of the Society of Toxicology     Volume:  28     ISSN:  0272-0590     ISO Abbreviation:  Fundam Appl Toxicol     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-12-04     Completed Date:  1996-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8200838     Medline TA:  Fundam Appl Toxicol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  177-86     Citation Subset:  IM    
Affiliation:
Developmental and Reproductive Toxicology Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn / growth & development
Body Weight / drug effects
Cocaine / administration & dosage,  toxicity*
Embryo, Mammalian / drug effects
Embryonic and Fetal Development / drug effects
Female
Fetal Death / chemically induced
Fetal Viability / drug effects
Fetus / abnormalities,  drug effects
Injections, Intraperitoneal
Kidney / abnormalities,  drug effects
Litter Size / drug effects
Male
Maternal Exposure
Mice
Mice, Inbred ICR
Narcotics / administration & dosage,  toxicity*
Pregnancy
Prenatal Exposure Delayed Effects
Chemical
Reg. No./Substance:
0/Narcotics; 50-36-2/Cocaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Developmental toxicity of inhaled N-methylformamide in the rat.
Next Document:  Assessment of the developmental toxicity and placental transfer of 1,2-dichloroethane in rats.